These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25205664)

  • 1. Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?
    Das S; Matlashewski G; Bhunia GS; Kesari S; Das P
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):679-84. PubMed ID: 25205664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.
    Das VN; Siddiqui NA; Verma RB; Topno RK; Singh D; Das S; Ranjan A; Pandey K; Kumar N; Das P
    Trans R Soc Trop Med Hyg; 2011 Nov; 105(11):661-6. PubMed ID: 21945327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India.
    Srivastava P; Gidwani K; Picado A; Van der Auwera G; Tiwary P; Ostyn B; Dujardin JC; Boelaert M; Sundar S
    Trop Med Int Health; 2013 May; 18(5):548-54. PubMed ID: 23464581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.
    Bimal S; Das VN; Sinha PK; Gupta AK; Verma N; Ranjan A; Singh SK; Sen A; Bhattacharya SK; Das P
    Ann Trop Med Parasitol; 2005 Dec; 99(8):743-9. PubMed ID: 16297287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological and Molecular Analysis of
    Kaushal H; Bhattacharya SK; Verma S; Salotra P
    Am J Trop Med Hyg; 2017 Jun; 96(6):1448-1455. PubMed ID: 28719266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.
    Das VN; Pandey RN; Siddiqui NA; Chapman LA; Kumar V; Pandey K; Matlashewski G; Das P
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005196. PubMed ID: 27974858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR; Bimal S; Siddiqui NA; Kumar A; Pandey K; Sinha SK; Topno RK; Mahentesh V; Singh AK; Lal CS; Singh SK; Das P
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J; Hasker E; Kansal S; Singh OP; Malaviya P; Singh AK; Chourasia A; Singh T; Sudarshan M; Singh AP; Singh B; Singh RP; Ostyn B; Fakiola M; Picado A; Menten J; Blackwell JM; Wilson ME; Sacks D; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
    Ostyn B; Gidwani K; Khanal B; Picado A; Chappuis F; Singh SP; Rijal S; Sundar S; Boelaert M
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1284. PubMed ID: 21991397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India.
    Mahajan R; Owen SI; Kumar S; Pandey K; Kazmi S; Kumar V; Adams ER; Harshana A; Burza S
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010718. PubMed ID: 36040931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E; Kansal S; Malaviya P; Gidwani K; Picado A; Singh RP; Chourasia A; Singh AK; Shankar R; Menten J; Wilson ME; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2013; 7(2):e2053. PubMed ID: 23459501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.
    Topno RK; Das VN; Ranjan A; Pandey K; Singh D; Kumar N; Siddiqui NA; Singh VP; Kesari S; Kumar N; Bimal S; Kumar AJ; Meena C; Kumar R; Das P
    Am J Trop Med Hyg; 2010 Sep; 83(3):502-6. PubMed ID: 20810810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of Leishmania donovani infection in high transmission foci in India.
    Singh SP; Picado A; Boelaert M; Gidwani K; Andersen EW; Ostyn B; Meheus F; Rai M; Chappuis F; Davies C; Sundar S
    Trop Med Int Health; 2010 Jul; 15 Suppl 2():12-20. PubMed ID: 20487420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.
    Cameron MM; Acosta-Serrano A; Bern C; Boelaert M; den Boer M; Burza S; Chapman LA; Chaskopoulou A; Coleman M; Courtenay O; Croft S; Das P; Dilger E; Foster G; Garlapati R; Haines L; Harris A; Hemingway J; Hollingsworth TD; Jervis S; Medley G; Miles M; Paine M; Picado A; Poché R; Ready P; Rogers M; Rowland M; Sundar S; de Vlas SJ; Weetman D
    Parasit Vectors; 2016 Jan; 9():25. PubMed ID: 26812963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA; Coffeng LE; Bontje DM; Hasker EC; Postigo JA; Argaw D; Boelaert MC; De Vlas SJ
    Parasit Vectors; 2016 Jan; 9():24. PubMed ID: 26787302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
    Sundar S; Singh OP; Chakravarty J
    Expert Rev Anti Infect Ther; 2018 Nov; 16(11):805-812. PubMed ID: 30289007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.
    Hirve S; Boelaert M; Matlashewski G; Mondal D; Arana B; Kroeger A; Olliaro P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004896. PubMed ID: 27490264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
    Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.